Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease

OBJECTIVE: Deposition of Aβ-containing plaques as evidenced by amyloid imaging and CSF Aβ42 is an early indicator of preclinical Alzheimer disease (AD). To better understand their relationship during the earliest preclinical stages, we investigated baseline CSF markers in cognitively normal individu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Neurol
Main Authors: Vlassenko, Andrei G., McCue, Lena, Jasielec, Mateusz S, Su, Yi, Gordon, Brian A., Xiong, Chengjie, Holtzman, David M, Benzinger, Tammie LS, Morris, John C, Fagan, Anne M
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016232/
https://ncbi.nlm.nih.gov/pubmed/27398953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24719
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares